Blood News and Research

RSS

Preeclampsia a significant risk factor for chronic hypertension and hospitalizations later in life

Ben-Gurion University of the Negev (BGU) researchers have determined that preeclampsia is a significant risk factor for long-term health issues, such as chronic hypertension and hospitalizations later in life.

6 Sep 2012

Study sheds new light on why most bone marrow transplant patients suffer acute GVHD

A team of scientists led by a bone marrow transplant researcher at Fred Hutchinson Cancer Research Center has shed new light on why most bone marrow transplant patients who receive tissue-matched cells from unrelated donors still suffer acute graft-versus-host disease (GVHD).

6 Sep 2012

Endovascular repair for abdominal aortic aneurysms has low rate of complications

A minimally invasive procedure known as endovascular repair used for abdominal aortic aneurysms has a low rate of complications, even in high-risk patients such as those with kidney, heart or lung problems, a Mayo Clinic study shows.

6 Sep 2012

TSC and PTEN genes important in controlling blood precursor cells in Drosophila

UCLA stem cell scientists have shown that two common tumor suppressor genes, TSC and PTEN, are vital to regulating the stem cell-like precursor cells that create the blood supply in Drosophila, the common fruit fly.

6 Sep 2012

Tips to deal with bed bugs when traveling

As VIPs come to Charlotte, N.C., for the Democratic National Convention, some are being greeted by undesirable guests in their hotels. No, not protesters. Bed bugs. Reports of the little blood-suckers have been on the uptick in Charlotte, and they are a growing problem in the lodging industry throughout the country. The good news: Delegates, and anyone who travels, can take precautions against bed bugs—small insects that feed on human blood and are usually active at night when people are sleeping.

6 Sep 2012

Exposure to household chemical may raise cardiac risk

Exposure to perfluorooctanoic acid may be associated with cardiovascular disease and peripheral arterial disease, say researchers.

5 Sep 2012

On-the-spot test aids postsurgical coagulopathy management

Point-of-care thromboelastometric and aggregometric testing helps to reduce exposure to allogenic blood products in patients with coagulopathy after cardiac surgery, a randomized trial shows.

5 Sep 2012

Arsenic induces acute promyelocytic leukemia remission

Elderly patients with acute promyelocytic leukemia have a high rate of response to arsenic trioxide, say researchers who believe the drug should be a first-line treatment in this population.

5 Sep 2012

More findings on genetic complexity behind type 2 diabetes

Using a new method, diabetes researchers at Lund University, Sweden, have been able to reveal more of the genetic complexity behind type 2 diabetes.

5 Sep 2012

Sleep apnoea severity associated with increased cancer mortality

Sleep apnoea severity has been associated with increased cancer mortality in a new study.

5 Sep 2012

Breastfeeding may lower risk for depression in adulthood

A study published in the last issue of Psychotherapy and Psychosomatics examines the relationship between breastfeeding and onset of depression in adulthood.

5 Sep 2012

S. African, S. Korean research team developing smartphone HIV testing device, application

Researchers from South Africa and South Korea are developing a smartphone-based device and application able to "photograph and analyze blood samples in areas far from laboratories to diagnose HIV and even measure the health of [patients'] immune systems," Agence France-Presse reports.

5 Sep 2012

Baxter seeks FDA BLA approval for BAX 326 rFIX protein to treat hemophilia B

Baxter International Inc. today announced that the company has submitted a biologics license application to the United States Food and Drug Administration for approval of BAX 326, a recombinant factor IX (rFIX) protein being investigated for the treatment and prophylaxis of bleeding episodes for patients over 12 years of age with hemophilia B.

From Baxter International Inc. 5 Sep 2012

FDA approves Bosulif to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Bosulif (bosutinib) to treat chronic myelogenous leukemia (CML), a blood and bone marrow disease that usually affects older adults.

5 Sep 2012

ImmusanT commences Nexvax2 clinical trials for celiac disease in New Zealand, Australia and the U.S.

ImmusanT announced today that it has initiated clinical trials in New Zealand, Australia and the U.S. to evaluate Nexvax2, the first therapeutic vaccine for patients with celiac disease. Nexvax2 is designed to re-establish patients' tolerance to the toxic effects of gluten, a protein in wheat, barley and rye, and allow them to return to a normal diet.

5 Sep 2012

Thermal imaging technology to identify drunks

Thermal imaging technology might one day be to identify drunks before they become a nuisance in bars, airports or other public spaces. Georgia Koukiou and Vassilis Anastassopoulos of the Electronics Laboratory, at University of Patras, Greece, are developing software that can objectively determine whether a person has consumed an excessive amount of alcohol based solely on the relative temperature of different parts of the person's face.

5 Sep 2012